The California-based company, founded in 1998 and now a subsidiary of Millipore Corp, specializes in the development and manufacturing of biotechnology and medical devices. Their product range includes HIV/AIDS monitoring, cell counting and viability assays, antibody quantification assays, apoptosis assay suite, cell cycle assays, cytotoxicity assays, cell proliferation assays, and benchtop cell analysis systems. These innovative flow cytometry systems find applications in various fields such as life science research, drug discovery and development, cell biology research, core flow cytometry, and clinical diagnostics markets. Guava Technologies' cutting-edge products are widely used for cell counting/viability, antibody quantification, cell cycle and proliferation, cytotoxicity, and apoptosis applications.